Jeschke, U.; Zhang, X.; Kuhn, C.; Jalaguier, S.; Colinge, J.; Pfender, K.; Mayr, D.; Ditsch, N.; Harbeck, N.; Mahner, S.;
et al. The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status. Int. J. Mol. Sci. 2019, 20, 1016.
https://doi.org/10.3390/ijms20051016
AMA Style
Jeschke U, Zhang X, Kuhn C, Jalaguier S, Colinge J, Pfender K, Mayr D, Ditsch N, Harbeck N, Mahner S,
et al. The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status. International Journal of Molecular Sciences. 2019; 20(5):1016.
https://doi.org/10.3390/ijms20051016
Chicago/Turabian Style
Jeschke, Udo, Xi Zhang, Christina Kuhn, Stéphan Jalaguier, Jacques Colinge, Kristina Pfender, Doris Mayr, Nina Ditsch, Nadia Harbeck, Sven Mahner,
and et al. 2019. "The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status" International Journal of Molecular Sciences 20, no. 5: 1016.
https://doi.org/10.3390/ijms20051016
APA Style
Jeschke, U., Zhang, X., Kuhn, C., Jalaguier, S., Colinge, J., Pfender, K., Mayr, D., Ditsch, N., Harbeck, N., Mahner, S., Sixou, S., & Cavaillès, V.
(2019). The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status. International Journal of Molecular Sciences, 20(5), 1016.
https://doi.org/10.3390/ijms20051016